Phase II trial of recombinant leukocyte A interferon (IFN-α2A) plus 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and the combination cimetidine with BCNU in patients with disseminated malignant melanoma

R. F. Morton, E. T. Creagan, D. J. Schaid, C. G. Kardinal, G. W. McCormack, M. S. McHale, M. Wiesenfeld

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of recombinant leukocyte A interferon (IFN-α2A) plus 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and the combination cimetidine with BCNU in patients with disseminated malignant melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences